Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Differing trends in the incidence of vascular comorbidity in MS and the general population.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Episode 24 with Professor Aksel Siva discussing asymptomatic MS
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
Epigenetics of Multiple Sclerosis: An Updated Review.
The use of hematopoietic stem cells in autoimmune diseases.
Interferon beta-1b
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.
Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis.
Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
Free MED IQ Live CME Event on Multiple Sclerosis Nov 22nd
Biogen Idec receives notification of PDUFA date extension
In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade.
Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients with Relapsing-Remitting Multiple Sclerosis.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis.
CCL genes in multiple sclerosis and systemic lupus erythematosus.
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).

Pages